Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, 58203, USA.
Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, 58203, USA.
Neuropharmacology. 2019 Jun;151:144-158. doi: 10.1016/j.neuropharm.2019.04.017. Epub 2019 Apr 15.
Nociceptin (NOP) is an endogenous opioid-like peptide that selectively activates the opioid receptor-like (ORL-1) receptors. The entorhinal cortex (EC) is closely related to temporal lobe epilepsy and expresses high densities of ORL-1 receptors. However, the functions of NOP in the EC, especially in modulating the epileptiform activity in the EC, have not been determined. We demonstrated that activation of ORL-1 receptors remarkably inhibited the epileptiform activity in entorhinal slices induced by application of picrotoxin or by deprivation of extracellular Mg. NOP-mediated depression of epileptiform activity was independent of synaptic transmission in the EC, but mediated by inhibition of neuronal excitability in the EC. NOP hyperpolarized entorhinal neurons via activation of K channels and inhibition of cation channels. Whereas application of Ba at 300 μM which is effective for the inward rectifier K (Kir) channels slightly inhibited NOP-induced hyperpolarization, the current-voltage (I-V) curve of the net currents induced by NOP was linear without showing inward rectification. However, a role of NOP-induced inhibition of cation channels was revealed after inhibition of Kir channels by Ba. Furthermore, NOP-mediated augmentation of membrane currents was differently affected by application of the blockers selective for distinct subfamilies of Kir channels. Whereas SCH23390 or ML133 blocked NOP-induced augmentation of membrane currents at negative potentials, application of tertiapin-Q exerted no actions on NOP-induced alteration of membrane currents. Our results demonstrated a novel cellular and molecular mechanism whereby activation of ORL-1 receptors depresses epilepsy.
孤啡肽(NOP)是一种内源性阿片样肽,选择性地激活阿片受体样(ORL-1)受体。内嗅皮层(EC)与颞叶癫痫密切相关,表达高浓度的 ORL-1 受体。然而,NOP 在 EC 中的功能,特别是在调节 EC 中的癫痫样活动方面,尚未确定。我们证明,激活 ORL-1 受体可显著抑制胡椒碱诱导或细胞外镁剥夺诱导的 EC 切片中的癫痫样活动。NOP 介导的癫痫样活动抑制与 EC 中的突触传递无关,但通过抑制 EC 中的神经元兴奋性来介导。NOP 通过激活 K 通道和抑制阳离子通道使内嗅神经元超极化。虽然在 300μM 时应用 Ba(对内向整流 K(Kir)通道有效)可轻微抑制 NOP 诱导的超极化,但由 NOP 诱导的净电流的电流-电压(I-V)曲线呈线性,没有表现出内向整流。然而,在抑制 Kir 通道后,揭示了 NOP 诱导的阳离子通道抑制的作用。此外,Kir 通道选择性阻断剂的应用对 NOP 介导的膜电流增强的作用不同。SCH23390 或 ML133 在负电位下阻断 NOP 诱导的膜电流增强,而 tertiapin-Q 对 NOP 诱导的膜电流变化无作用。我们的结果证明了一种新的细胞和分子机制,通过激活 ORL-1 受体抑制癫痫。